Introduction
The typical clinical presentation of Guillain-Barre syndrome is one of areflexic flaccid and symmetrical motor paralysis associated with an elevated protein and normal cell count in the cerebrospinal fluid (CSF). Motor involvement of the cranial nerves is seen in up to 50% but sensory symptoms are usually minor. The onset of weakness usually occurs over a period of several days and often follows a prodromal infective illness. Motor symptoms may progress for up to 4 weeks, after which there is a stable period followed by a gradual and slow improvement which may be delayed for up to 2 months.', We present a patient in whom the clinical progression and laboratory findings were typical of Guillain-Barre syndrome and a computed tomographic (CT) scan of the head was normal. He was given a full course of immunoglobulins and ventilated for 10 weeks before neurological deterioration led to the diagnosis of a malignant astrocytoma of the cervico-medullary junction.
Case report A 33 year old male presented with a one week history of progressive ascending weakness, headache and respiratory difficulty. His symptoms developed 3 weeks after a prodromal illness characterized by a sore throat and productive cough. On examination he was severely dyspnoeic. His heart rate was 110 beats per minute, blood pressure 150/80 mmHg, respiratory rate 36 per minute and temperature 38.4°C. His chest was clear to auscultation. He had severe (Grade IV) motor weakness in both upper and lower limbs with depressed peripheral reflexes, and downgoing plantar responses. There were no cranial nerve deficits and no signs of sensory deficit despite paraesthesia in both hands and feet. The fundi were normal and there was no evidence of meningism. The chest X-ray demonstrated minor bilateral lower zone consolidation.
Arterial blood gases showed evidence of type II respiratory failure. The patient was intubated and mechanically ventilated and tranferred to the intensive care unit. An urgent CT scan was performed both with and without intravenous iodinated contrast. Images were obtained from the C2 vertebra to the vertex and revealed no apparent abnormality. The fourth ventricle was midline and there was no evidence of either abnormal enhancement or mass effect within the posterior fossa or upper spinal canal (Figure 1 ). Laboratory investigations demonstrated a leucocytosis of 11.3 x 109/l, other routine haematological and biochemical investigations were normal. Lumbar puncture yielded clear colourless CSF, the protein was markedly elevated (1.19 g/l) but microscopy showed no cells and CSF glucose and chloride levels were normal.
After a period of initial stabilization, the patient required continuing ventilatory support with an inspired oxygen concentration of 0.5 to maintain an acceptable Pao2. Neurological examination at this stage demonstrated a profound flaccid and areflexic quadriparesis with no sensory disturbance and no involvement of the cranial nerves. Repeat lumbar puncture performed one week after admission showed a rise in CSF protein to 7.4 g/l but was again otherwise normal, and all CSF cultures were negative. Serological tests for legionnaires' disease, chlamydia, syphilis and recent viral infection were negative, however, titre of both IgG and IgM antibodies to Mycoplasma sp. were significantly raised. On the basis of these findings, diagnosis of Guillain-Barre syndrome was made.
The patient's neurological status remained unchanged for a period of 8 weeks at which time he developed bilateral sixth nerve palsies and his conscious level deteriorated. A repeat CT scan revealed a large enhancing posterior fossa mass arising in the cervico-medullaryjunction and growing up into the obex (Figure 2 ). The fourth ventricle remained midline, and the third and lateral ventricles were dilated requiring ventriculo-peritoneal shunt insertion. CT cisternography at the time of shunt insertion and subsequent CT myelography demonstrated expansion of the medulla oblongata below the level of the third ventricle with almost complete block of the subarachnoid space at the level of the foramen magnum (Figure 3) . The expansion of the medulla extended down into the spinal canal to approximately the level of the Cl -C2 junction. Surgical exploration revealed a grey smooth gelatinous mass infiltrating the upper cervical cord in the region of Cl and extending superiorly into the obex to displace the cerebellar hemispheres laterally and the vermis cephalad. No attempt at resection was made although a superficial biopsy was obtained. Histological examination revealed a grade IV astrocytoma. The patient deteriorated rapidly after surgery and remained comatose until his death 8 days later.
Discussion
Guillain-Barre syndrome is one of a spectrum of inflammatory polyradiculoneuropathies which In the present case a malignant astrocytoma of the cervico-medullary junction replicated the clinical and CSF abnormalities leading to a mistaken diagnosis of Guillain-Barre syndrome. Although malignant gliomas of the cervicomedullary junction are extremely rare, it is of interest that Hankey2 mentions a similar case which was entered into a prospective study of Guillain-Barre syndrome and subsequently excluded when a glioma of the upper cervical cord was diagnosed.
In adults brainstem gliomas are rare, forming less than 5% of intracranial tumours of which less than 10% are malignant.5 6 Malignant brainstem gliomas are commonest in the pons, although up to 30% occur at the cervico-medullary junction.5-'
Clinical presentation is one of very rapid onset of progressive neurological impairment with extremely variable clinical signs depending on the site of origin of the tumour.67 CSF abnormalities are invariably present and marked elevation of CSF protein is common.5 '6 In the present case the tumour presumably arose in the ventral aspect of the upper cervical cord where invasion of the medial lemniscus and pyramidal tract caused paraesthesia and progressive motor deficit mimicking the clinical presentation of Guillain-Barre syndrome.8 It is important to realize that intrinsic tumours arising higher in the brainstem or at lower levels in the spinal cord would not cause dissociated motor weakness since motor and sensory pathways lie in close proximity.8
Imaging studies of the cervico-medullary junction are notoriously difficult and the normal initial CT scan was one of the major obstacles to the diagnosis of the present case. Brainstem gliomas exhibit an infiltrative growth pattern and are only rarely associated with oedema or enhancement so that CT reveals only subtle enlargement of the brainstem.5'9'10 This may be extremely difficult to appreciate, particularly at the cervico-medullary junction where streak artifact is inevitable. The introduction of magnetic resonance imaging (MRI) has improved imaging of the brainstem and spinal cord, and CT will miss up to 20% of brainstem gliomas demonstrated on MRI.5,7,9,10 Furthermore, MRI is not generally available and is associated with considerable difficulties in ventilated patients.
The most effective clinical test to distinguish between the polyradiculopathy of Guillain-Barre syndrome and motor paresis of central origin is the measurement of peripheral nerve conduction. In the present case, nerve conduction studies were not performed but would have been expected to be normal. In contrast Guillain-Barre is associated with slowing of motor conduction velocity and decreased amplitude of motor potentials, although these changes may not be seen in the early stages of the disease when inflammation is limited to the nerve roots.
Although CSF protein analysis was not performed in the present case, it is possible that it may have provided a diagnostic clue. The elevation of CSF protein in Guillain-Barre syndrome is almost entirely due to an increase in albumin content and is thought to represent passage of plasma contents through the damaged blood-brain barrier.3'4 The elevation of CSF protein associated with spinal cord and brainstem tumours can be similar in composition but may sometimes demonstrate elevation of one or more of the globulin components due to tumoral protein synthesis.
In conclusion an intrinsic tumour of the cervicomedullary junction may mimic the clinical presentation and CSF findings classically associated with Guillain-Barre syndrome. The location of a tumour with these clinical features is most likely to be the cervico-medullary junction where CT is of least use. CSF protein analysis may provide a clue as to the underlying pathology but may also be in keeping with Guillain-Barre syndrome. Wherever possible we would recommend confirmation of the diagnosis of Guillain-Barre syndrome by measurement ofperipheral nerve motor potentials. Preservation of motor potentials, elevation of CSF globulin level or any variation from the expected clinical course, as seen in the present case, should prompt more aggressive neuroradiological investigation.
